Glucose

Your blood sugar is the clearest window into how your body handles food, and the cost of getting it wrong compounds quietly for years. Using single-test estimates, roughly one in four U.S. adults with type 2 diabetes does not know they have it, and the disease typically begins years before anyone gets diagnosed, with metabolic changes detectable 4 to 7 years (and in some studies more than a decade) ahead of diagnosis. Complications can start during that hidden window.

Glucose (a simple six-carbon sugar that comes from the food you eat and is also made by your liver) is the answer to a simple question: is your body keeping fuel balanced minute to minute, or is it starting to lose control? Knowing your number gives you years of lead time to act before damage to nerves, kidneys, eyes, and arteries becomes irreversible.

What This Test Measures

This test measures the concentration of glucose in the liquid part of your blood (plasma or serum) after at least 8 hours of fasting. In the fasting state, your liver does the work of keeping glucose steady by breaking down stored sugar and making new sugar from precursors like lactate and the amino acid alanine. Two hormones run the show: insulin pushes glucose down by telling cells to take it up, and glucagon pushes it up by telling the liver to release more.

What you see on the lab report is the net result of that balance at a single moment. If your fasting glucose is rising over time, it usually means your body is producing more sugar than your tissues can absorb, which is the core problem in type 2 diabetes.

Heart Attack and Stroke Risk

Even before glucose crosses the diabetes threshold, higher fasting numbers raise your cardiovascular risk in a steady, dose-dependent way. A pooled analysis of about 820,900 adults found that for every 18 mg/dL rise in fasting glucose above 100 mg/dL, the risk of dying from heart disease or stroke went up by 13%. The risk of dying from any cause went up by 10%.

The jump becomes substantial once you cross into the diabetes range. Compared to people with fasting glucose between 70 and 100 mg/dL, those at 126 mg/dL or higher were about 89% more likely to die from vascular disease (hazard ratio 1.89) and 39% more likely to die from cancer (hazard ratio 1.39), even after excluding people already diagnosed with diabetes.

A meta-analysis of 53 studies covering more than 1.6 million people followed for a median of 9.5 years showed that even the prediabetes range matters. People with impaired fasting glucose (100 to 125 mg/dL) had about 13% higher risk of heart disease and stroke combined, and about 13% higher all-cause mortality than people with normal glucose. Impaired glucose tolerance (a higher-than-normal reading 2 hours after a sugar drink) carried a 30% jump in cardiovascular risk.

Cancer Risk

The connection between high glucose and cancer is less widely understood than the heart link, but the data are consistent. In a six-cohort European study of about 550,000 adults followed for an average of 10.4 years, each 18 mg/dL rise in fasting glucose was linked to roughly 5% higher cancer incidence in men and 11% higher in women. For fatal cancer, the increases were 15% and 21%.

In a Swedish prospective study of about 64,500 adults, women in the top quarter of fasting glucose had about 26% higher risk of any cancer than those in the bottom quarter. After correcting for measurement noise, that estimate climbed to 75%. The strongest links were for pancreatic (about 2.5 times the risk in the high group), endometrial (about 1.9 times), and urinary tract cancers. These associations held independent of body weight.

Kidney, Nerve, and Eye Damage

A Danish genetic study of 117,193 people used naturally occurring gene variants to test whether glucose actually causes microvascular damage, rather than just traveling with it. For every 18 mg/dL increase in glucose, the risk of diabetic retinopathy roughly doubled (about 2 times higher), nerve damage went up about 2.2 times, and diabetic kidney disease went up about 1.6 times. Because this design rules out most confounding, the results strongly support glucose itself as the driver, not a marker.

In a Korean cohort of 183,049 people with diabetes followed for 9 years, major kidney events occurred in 15.4% of those with protein in the urine and 10.8% of those with reduced kidney filtration. The relationship between glucose and kidney damage was J-shaped, meaning both very high and very low glucose carried risk.

What Low Glucose Means

Hypoglycemia is glucose below 70 mg/dL. Most cases happen in people taking insulin or sulfonylureas for diabetes, but it can also signal an insulin-producing tumor (insulinoma), adrenal insufficiency, severe liver or kidney disease, or alcohol toxicity. Severe lows can cause loss of consciousness, seizures, and increased mortality. If you are not on glucose-lowering medication and your fasting reading is below 70 mg/dL, that warrants follow-up to find the cause.

Why One Reading Is Not Enough

Glucose moves around more than most people realize. The within-person coefficient of variation (a measure of how much one person's results bounce around from one test to the next) is about 4.8% to 5.7% for fasting glucose in healthy adults, and about 7.1% in people with previously undiagnosed diabetes. In practical terms, a true fasting glucose of 126 mg/dL has a 95% range of about 110 to 142 mg/dL when you account for biological and lab variation together. That overlaps the normal, prediabetes, and diabetes ranges.

That is why the American Diabetes Association requires two abnormal readings before diagnosing diabetes (unless you have clear symptoms or a hyperglycemic crisis). A single number near a threshold can lead you to the wrong conclusion in either direction.

For trending, get a baseline fasting glucose now. If you are making changes to diet, exercise, or weight, retest in 3 to 6 months to see whether your trajectory is moving the right way. After that, at least once a year. If you are over 35, the ADA recommends screening every 3 years at minimum, but for someone actively managing their health, annual is the floor and 6-month intervals during active change make more sense.

When Results Can Be Misleading

A single fasting glucose can mislead you in several ways. The most common pitfalls:

• Inadequate fasting: Eating within 8 hours of the draw can raise the result and push you into a prediabetes range you would not actually meet on a true fasting test.
• Time of day: Fasting glucose drops by about 7 to 8 mg/dL between 8 AM and 3 PM. A 9 AM draw and a 2 PM draw on the same day can land in different diagnostic categories. Get tested first thing in the morning for consistency.
• Acute illness, stress, or recent intense exercise: Stress hormones like cortisol and adrenaline raise glucose. A reading taken during a cold, after a poor night's sleep, or the morning after a hard workout can run higher than your true baseline. Stress hyperglycemia happens in 30 to 40% of people hospitalized for acute illness.
• Delayed sample processing: Red blood cells keep consuming glucose after the blood is drawn. If your sample sits too long before processing, the result can come back falsely low.

Several common medications can also raise glucose without causing diabetes itself, which can make a single reading misleading if you do not know to account for them. Corticosteroids (prednisone, dexamethasone) cause hyperglycemia in 18 to 32% of people on supraphysiologic doses, mostly after meals rather than fasting. Statins modestly raise glucose: moderate-intensity statins raise diabetes risk about 10%, high-intensity statins about 36%, but the absolute change in HbA1c (a 3-month average of glucose) is only 0.06 to 0.08%. Thiazide diuretics, second-generation antipsychotics, certain HIV medications, and tacrolimus also raise glucose. If you are on any of these, mention them when interpreting results.

How This Differs from HbA1c

Fasting glucose tells you what your blood sugar is right now. HbA1c (a measure of how much glucose has stuck to your red blood cells over the past 2 to 3 months) tells you the average over time. They are not interchangeable, and each catches things the other misses.

Fasting glucose alone has about 49% sensitivity and 98% specificity for diagnosing diabetes when compared to the oral glucose tolerance test (the most thorough method). HbA1c has about 51% sensitivity and 96% specificity. Using both together raises sensitivity to 64%. The two tests identify overlapping but not identical groups, and concordance for prediabetes between fasting glucose, 2-hour glucose, and HbA1c can be as low as 4%. For the clearest picture, get both.

What to Do with an Out-of-Pattern Result

If your fasting glucose comes back in the prediabetes range (100 to 125 mg/dL) or higher, do not stop there. Going beyond standard guideline screening, some clinicians pair glucose and HbA1c with fasting insulin to get a fuller picture. An elevated fasting insulin alongside a borderline glucose can suggest insulin resistance even if your sugar is still being held in range, sometimes years before glucose actually moves. This more proactive workup is not part of standard ADA diabetes diagnosis guidelines but is used in preventive and functional medicine settings.

For a confirmed abnormal result, the next steps usually include: a repeat fasting glucose to confirm (ideally within a few weeks, in the morning, after a true 8-hour fast); an HbA1c if not already done; and a lipid panel, since dyslipidemia and elevated glucose travel together. Fasting insulin and HOMA-IR (a calculation that estimates insulin resistance) can add information beyond standard screening. If your fasting glucose is normal but you have risk factors (family history, high BMI, polycystic ovary syndrome, history of gestational diabetes), consider a 2-hour oral glucose tolerance test, which catches people whose fasting numbers look fine but whose post-meal numbers spike. A study across 27 countries in coronary artery disease patients found that 2-hour glucose was the most reliable predictor of future cardiovascular events, while fasting glucose alone added nothing.

If you are repeatedly getting borderline or abnormal results despite lifestyle changes, that is the point to involve an endocrinologist or your primary care physician for a deeper workup, which may include autoantibodies (to rule out type 1 diabetes in adults), C-peptide (to distinguish insulin deficiency from insulin resistance), and screening for kidney involvement with a urinary albumin-to-creatinine ratio.